Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen
Publikationen
Ergebnisse pro Seite:  10

Distler, Ute; Kuharev, Joerg; Navarro, Pedro et al.

Label-free quantification in ion mobility-enhanced data-independent acquisition proteomics

NATURE PROTOCOLS. Bd. 11. H. 4. 2016 S. 795-812


Luther, N.; Bohn, T.; Schmitt, E. et al.

Local cyclic nucleotide repression inhibits Melanoma growth

EXPERIMENTAL DERMATOLOGY. Bd. 25. 2016 S. 11-11


Vogt, Johannes; Yang, Jenq-Wei; Mobascher, Arian et al.

Molecular cause and functional impact of altered synaptic lipid signaling due to a prg-1 gene SNP

EMBO MOLECULAR MEDICINE. Bd. 8. H. 1. 2016 S. 25-38


Vormehr, Mathias; Diken, Mustafa; Boegel, Sebastian et al.

Mutanome directed cancer immunotherapy

CURRENT OPINION IN IMMUNOLOGY. Bd. 39. 2016 S. 14-22


Kerstan, A.; Alrefai, H.; Muhammad, K. et al.

NFATc1 promotes imiquimod-induced skin inflammation by negatively controlling IL-10 production in B cells

EXPERIMENTAL DERMATOLOGY. Bd. 25. H. 3. 2016 S. E26-E26


Muhammad, K.; Alrefai, H.; Rudolf, R. et al.

NFATc1 supports imiquimod- induced skin inflammation by suppressing regulatory B cells

EUROPEAN JOURNAL OF IMMUNOLOGY. Bd. 46. 2016 S. 1136-1136


Alrefai, Hani; Muhammad, Khalid; Rudolf, Ronald et al.

NFATc1 supports imiquimod-induced skin inflammation by suppressing IL-10 synthesis in B cells

NATURE COMMUNICATIONS. Bd. 7. 2016


Alrefai, Hani; Muhammad, Khalid; Rudolf, Ronald et al.

NFATc1 supports imiquimod-induced skin inflammation by suppressing IL-10 synthesis in B cells (vol 7, 11724, 2016)

Nature Communications. Bd. 7. 2016



Krebs, F.; Hahn, S.; Mitzel, H. et al.

Novel prognostic marker proteins for malignant melanoma immunotherapy

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 14. 2016 S. 23-23